• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CURONIX LLC FREEDOM PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CURONIX LLC FREEDOM PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number STQ4-RCV-B0, STQ4-RCV-A0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Impaired Healing (2378)
Date of Event 05/15/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The surgical issue questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device after the expiration date, not prepping the surface of the skin with an antiseptic solution, not irrigating the incision site with an antibiotic solution before closure, improperly closing the surgical site, multiple tunneling attempts, using inappropriate tools, and not prescribing antibiotics pre-operatively have been ruled out.Additionally, the patient touching or picking at the wound, the device being implanted off-label, and the patient having contraindicating conditions have been ruled out.A curonix representative conducted a review of sterilization and packaging records for the respective product lot; curonix has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.The cause of the impaired healing is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, the conclusion has been selected as unable to determine the root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in surgical issues.Surgical issue rates remain acceptably low; thus, a capa is not required at this time.Surgical issue rates will continue to be tracked and trended.
 
Event or Problem Description
The patient reported impaired healing at the receiver site.Antibiotics were prescribed and as of on (b)(6) 2026, the patient reported significant improvement in wound healing.Additionally, the patient reported significant improvement with >90% pain relief.As of on (b)(6) 2026, the wound is closed, the patient completed their antibiotics and continues to use the neurostimulator and reported significant improvement in knee pain.No further issues have been reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREEDOM PERIPHERAL NERVE STIMULATOR
Common Device Name
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
CURONIX LLC
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
CURONIX LLC
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
alicia pagliaro
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key25587894
Report Number3010676138-2026-00106
Device Sequence Number5752599
Product Code GZF
UDI-Device Identifier00850051034413
UDI-Public(01)00850051034413(17)280301
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K233162
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 06/22/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberSTQ4-RCV-B0, STQ4-RCV-A0
Device Lot NumberSWO260313, SWO260223
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/29/2026
Initial Report FDA Received Date06/22/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/04/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age72 YR
Patient SexFemale
-
-